NEXOBRID Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for NEXOBRID with the United States Patent and Trademark Office. The USPTO has given the NEXOBRID trademark a serial number of 79286826. The federal status of this trademark filing is REGISTERED as of Tuesday, July 13, 2021. This trademark is owned by MediWound Ltd.. The NEXOBRID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical drug preparations and products, namely, an enzyme used in treatment of burns and wounds
nexobrid

General Information

Serial Number79286826
Word MarkNEXOBRID
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, July 13, 2021
Registration Number6413522
Registration DateTuesday, July 13, 2021
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical drug preparations and products, namely, an enzyme used in treatment of burns and wounds
Description of MarkThe mark consists of the stylized wording "NEXOBRID", with the left slanting leg of the "X" emanating extended curved lines.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMediWound Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL
Party NameMediWound Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL
Party NameMediWound Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events

Event DateEvent Description
Thursday, June 4, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 9, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, July 28, 2020ASSIGNED TO EXAMINER
Thursday, July 30, 2020NON-FINAL ACTION WRITTEN
Friday, July 31, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 31, 2020REFUSAL PROCESSED BY MPU
Sunday, September 6, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, September 27, 2020REFUSAL PROCESSED BY IB
Thursday, March 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 7, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 7, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, April 24, 2021NOTIFICATION PROCESSED BY IB
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, October 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 9, 2021FINAL DISPOSITION PROCESSED
Tuesday, November 9, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, November 28, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 3, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 13, 2026COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Related Keywords

nexobrid used treatment burns wounds enzyme namely drug preparations products pharmaceutical